Effectiveness of the Transoral Endoscopic Vertical Gastroplasty (TOGa®): a Good Balance Between Weight Loss and Complications, if Compared with Gastric Bypass and Biliopancreatic Diversion

Abstract

In selected patients, TOGa®, was associated with good results after two years in terms of weight loss, even in comparison with LRYGBP and BPD. Minimal trauma, absence of complications, and short hospital stay justify this procedure for patients with low BMI.

Natural Orifice Translumenal Endoscopic Surgery: Review of Its Applications in Bariatric Procedures

“…The hospital stay in these patients was significantly reduced compared to hNSG. Disregarding the Devière and Moreno papers, the other participants in the other studies [ 21 – 24 ] were either discharged the same day, or kept overnight for observation only. There was one exception [ 21 ] where a patient was admitted for 72 h with abdominal pain that resolved with conservative management.…”

“…The TOGa system was utilised in three studies with no differences in technique noted [ 19 , 20 , 24 ]. Devière et al [ 19 ] placed patients supine and used an upper endoscope to locate the Z-line.…”

Obesity and Diabetes

“…Outlet restriction can then be deployed. Studies implementing this technique on 29 morbidly obese patients showed no serious early or late complications, and documented an EWL% of 43 % at 12 months and 37 % at 24 months (Nanni et al 2012).…”

New endoscopic procedures for diabetes mellitus type 2 and obesity treatment

“…The promising results incentivized the development of other similar endoscopic device: studies based on different device, demonstrated a 1-year % EWL range from 27.7±21.9 to 58.1±19.9 (19)(20)(21), confirming that restrictive procedures are the most effective in terms of weight loss. Regarding metabolic effects and diabetes control, those studies also reported significant improvements in hemoglobin A1c, declining from 7.0% to 5.7% (22). Although comforting results in weight reduction and diabetes control associated with very few described adverse events, endoscopic controls at 1 year demonstrated only a partial sleeve maintained, with a partial or complete release of plication up to 72% of patients (20).…”